Dashboard
Manage Tickers

TEVATEVA PHARMACEUTICAL INDUSTR...

NYSE tevapharm.com


$ 16.25 $ -0.01 (-0.06 %)    

Friday, 28-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 16.25
$ 16.39
$ 0.00 x 0
$ 0.00 x 0
$ 16.16 - $ 16.47
$ 7.42 - $ 17.69
7,730,771
na
18.41B
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-12-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-10-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 05-03-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 10-27-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-10-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-19-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 02-12-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

teva-pharmaceuticals-presents-4th-interim-analysis-of-pearl-migraine-prevention-study-at-ean-congress-new-sub-analysis-highlights-potential-negative-impact-of-treatment-pauses-on-patient-outcomes
Teva Pharmaceuticals Presents 4th Interim ...
06/28/2024 15:31:15

4th interim analysis of PEARL real world migraine prevention study presented at 10th European Association of Neurology (EAN) co...

breaking-down-teva-pharmaceutical-indus-5-analysts-share-their-views
Breaking Down Teva Pharmaceutical Indus: 5...
06/27/2024 16:00:36

jefferies-maintains-buy-on-teva-pharmaceutical-indus-raises-price-target-to-23
Jefferies Maintains Buy on Teva Pharmaceut...
06/27/2024 15:37:35

Jefferies analyst Glen Santangelo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price target fro...

teva-expects-no-impact-from-israel-tax-authority-agreement-on-its-2024-financial-outlook-which-it-reaffirms
Teva Expects No Impact From Israel Tax Aut...
06/25/2024 12:04:08

teva-enters-agreement-with-israel-tax-authority-resolving-all-pending-litigation-agrees-to-pay-total-of-750m-in-installments-between-2024-to-2029
Teva Enters Agreement With Israel Tax Auth...
06/25/2024 12:02:29

This allows Teva to end this historical income tax issue, and to continue to focus on its commitment to the health of patients ...

teva-pharmaceutical-industries-launches-authorized-generic-of-victoza-in-united-states
Teva Pharmaceutical Industries Launches Au...
06/24/2024 13:50:55

Generic Victoza® is the first-ever generic GLP-1 and supports increased demand for this category of therapies in the U.S. marke...

teva-engages-in-settlement-talks-over-medicare-kickback-allegations
Teva Engages In Settlement Talks Over Medi...
06/18/2024 18:24:02

Teva Pharmaceutical is negotiating with the DOJ to settle a lawsuit alleging it paid kickbacks through charities to boost Copax...

concerpt-therapeutics-shares-are-trading-lower-what-you-need-to-know
Concerpt Therapeutics Shares Are Trading L...
06/14/2024 18:54:41

Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceu...

Core News & Articles
Reported Late Thursday: Teva Sues Corcept ...
06/14/2024 16:31:28

Teva sues Corcept over mifepristone 'monopoly' for rare disorder | Reuters

if-you-invested-1000-in-this-stock-5-years-ago-you-would-have-2100-today
If You Invested $1000 In This Stock 5 Year...
06/12/2024 17:02:00

Core News & Articles
Reported Monday June 10, 2024 "Amneal, U.S...
06/11/2024 14:40:07

https://www.reuters.com/legal/litigation/amneal-us-ftc-win-order-removing-teva-inhaler-patents-fda-list-2024-06-10/ Drugmaker A...

barclays-maintains-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-21
Barclays Maintains Overweight on Teva Phar...
06/05/2024 15:20:00

Barclays analyst Balaji Prasad maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price target...

teva-announced-saturday-switching-to-uzedy-at-four-weeks-after-the-last-dose-of-once-monthly-paliperidone-palmitate-provided-the-most-comparable-pharmacokinetic-profile-based-on-the-relevant-pk-modeling-data-for-schizophrenia
Teva Announced Saturday, Switching To UZED...
06/02/2024 18:33:49

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),today announced the present...

4-analysts-assess-teva-pharmaceutical-indus-what-you-need-to-know
4 Analysts Assess Teva Pharmaceutical Indu...
05/30/2024 16:01:09

b-of-a-securities-maintains-buy-on-teva-pharmaceutical-indus-raises-price-target-to-21
B of A Securities Maintains Buy on Teva Ph...
05/30/2024 15:45:08

B of A Securities analyst Jason Gerberry maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Buy and raises the price tar...

reported-earlier-tevas-austedo-xr-receives-fda-green-light-one-pill-once-daily-dosage-now-available-for-td-and-hd-chorea
Reported Earlier, Teva's AUSTEDO XR Receiv...
05/30/2024 07:16:14

U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets (30, 36, 42, 48 mg/day) AUSTEDO XR offers more flexibility wit...

teva-pharmaceutical-induss-options-frenzy-what-you-need-to-know
Teva Pharmaceutical Indus's Options Frenzy...
05/22/2024 16:01:48

Core News & Articles
Reported Earlier, Teva And Alvotech Announ...
05/21/2024 06:57:27

cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch
Cannabis Meets Prescription Drugs, Steroid...
05/18/2024 14:19:14

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...

piper-sandler-reiterates-overweight-on-teva-pharmaceutical-indus-raises-price-target-to-20
Piper Sandler Reiterates Overweight on Tev...
05/13/2024 12:46:08

Piper Sandler analyst David Amsellem reiterates Teva Pharmaceutical Indus (NYSE:TEVA) with a Overweight and raises the price...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)